The effects of Anethum graveolens (dill) powder supplementation on clinical and metabolic status in patients with type 2 diabetes
Abstract Background The objective of this study was to investigate the effects of Anethum graveolens (dill) powder supplementation on glycemic control, lipid profile, some antioxidants and inflammatory markers, and gastrointestinal symptoms in patients with type 2 diabetes. Materials and methods In...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-06-01
|
Series: | Trials |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13063-020-04401-3 |
id |
doaj-0a5d47a2109c431e9cfa6ca8543f6c77 |
---|---|
record_format |
Article |
spelling |
doaj-0a5d47a2109c431e9cfa6ca8543f6c772020-11-25T02:46:59ZengBMCTrials1745-62152020-06-0121111110.1186/s13063-020-04401-3The effects of Anethum graveolens (dill) powder supplementation on clinical and metabolic status in patients with type 2 diabetesFatemeh Haidari0Mehrnoosh Zakerkish1Fatemeh Borazjani2Kambiz Ahmadi Angali3Golnaz Amoochi Foroushani4Department of Nutrition, Nutrition and Metabolic Diseases Research Center, Ahvaz Jundishapur University of Medical SciencesHealth Research Institute, Diabetes Research Center, Ahvaz Jundishapur University of Medical SciencesDepartment of Nutrition, Nutrition and Metabolic Diseases Research Center, Ahvaz Jundishapur University of Medical SciencesDepartment of Biostatistic, School of Health, Ahvaz Jundishapur University of Medical SciencesHealth Research Institute, Diabetes Research Center, Ahvaz Jundishapur University of Medical SciencesAbstract Background The objective of this study was to investigate the effects of Anethum graveolens (dill) powder supplementation on glycemic control, lipid profile, some antioxidants and inflammatory markers, and gastrointestinal symptoms in patients with type 2 diabetes. Materials and methods In this study, 42 patients with type 2 diabetes were randomly allocated to intervention and control groups and received either 3 g/day dill powder or placebo (3 capsules/day, 1 g each). Fasting blood sugar, insulin, homeostatic model assessment of insulin resistance, lipid profile, high-sensitivity C-reactive protein, total antioxidant capacity, malondialdehyde and gastrointestinal symptoms were measured in all of the subjects at baseline and postintervention. Results The dill powder supplementation significantly decreased the mean serum levels of insulin, homeostatic model assessment of insulin resistance, low-density lipoprotein cholesterol, total cholesterol and malondialdehyde in the intervention group in comparison with the baseline measurements (P < 0.05). Furthermore, the mean serum levels of high-density lipoprotein and total antioxidant capacity were significantly increased in the intervention group in comparison with the baseline measurement (P < 0.05). Colonic motility disorder was the only gastrointestinal symptom whose frequency was significantly reduced by supplementation (P = 0.01). The mean changes in insulin, low-density lipoprotein cholesterol, total cholesterol and malondialdehyde were significantly lower in the intervention group than in the control group (P < 0.05). In addition, the mean changes in high-density lipoprotein were significantly higher in the intervention group than in the control group (P < 0.05). Conclusion Dill powder supplementation can be effective in controlling the glycemic, lipid, stress oxidative and gastrointestinal symptoms in patients with type 2 diabetes. Trial registration Iran Clinical Trials Registry: IRCT20120704010181N12 . Registered on 12 May 2018.http://link.springer.com/article/10.1186/s13063-020-04401-3Type 2 diabetesDill powderGlycemic controlLipid profileStress oxidative status |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Fatemeh Haidari Mehrnoosh Zakerkish Fatemeh Borazjani Kambiz Ahmadi Angali Golnaz Amoochi Foroushani |
spellingShingle |
Fatemeh Haidari Mehrnoosh Zakerkish Fatemeh Borazjani Kambiz Ahmadi Angali Golnaz Amoochi Foroushani The effects of Anethum graveolens (dill) powder supplementation on clinical and metabolic status in patients with type 2 diabetes Trials Type 2 diabetes Dill powder Glycemic control Lipid profile Stress oxidative status |
author_facet |
Fatemeh Haidari Mehrnoosh Zakerkish Fatemeh Borazjani Kambiz Ahmadi Angali Golnaz Amoochi Foroushani |
author_sort |
Fatemeh Haidari |
title |
The effects of Anethum graveolens (dill) powder supplementation on clinical and metabolic status in patients with type 2 diabetes |
title_short |
The effects of Anethum graveolens (dill) powder supplementation on clinical and metabolic status in patients with type 2 diabetes |
title_full |
The effects of Anethum graveolens (dill) powder supplementation on clinical and metabolic status in patients with type 2 diabetes |
title_fullStr |
The effects of Anethum graveolens (dill) powder supplementation on clinical and metabolic status in patients with type 2 diabetes |
title_full_unstemmed |
The effects of Anethum graveolens (dill) powder supplementation on clinical and metabolic status in patients with type 2 diabetes |
title_sort |
effects of anethum graveolens (dill) powder supplementation on clinical and metabolic status in patients with type 2 diabetes |
publisher |
BMC |
series |
Trials |
issn |
1745-6215 |
publishDate |
2020-06-01 |
description |
Abstract Background The objective of this study was to investigate the effects of Anethum graveolens (dill) powder supplementation on glycemic control, lipid profile, some antioxidants and inflammatory markers, and gastrointestinal symptoms in patients with type 2 diabetes. Materials and methods In this study, 42 patients with type 2 diabetes were randomly allocated to intervention and control groups and received either 3 g/day dill powder or placebo (3 capsules/day, 1 g each). Fasting blood sugar, insulin, homeostatic model assessment of insulin resistance, lipid profile, high-sensitivity C-reactive protein, total antioxidant capacity, malondialdehyde and gastrointestinal symptoms were measured in all of the subjects at baseline and postintervention. Results The dill powder supplementation significantly decreased the mean serum levels of insulin, homeostatic model assessment of insulin resistance, low-density lipoprotein cholesterol, total cholesterol and malondialdehyde in the intervention group in comparison with the baseline measurements (P < 0.05). Furthermore, the mean serum levels of high-density lipoprotein and total antioxidant capacity were significantly increased in the intervention group in comparison with the baseline measurement (P < 0.05). Colonic motility disorder was the only gastrointestinal symptom whose frequency was significantly reduced by supplementation (P = 0.01). The mean changes in insulin, low-density lipoprotein cholesterol, total cholesterol and malondialdehyde were significantly lower in the intervention group than in the control group (P < 0.05). In addition, the mean changes in high-density lipoprotein were significantly higher in the intervention group than in the control group (P < 0.05). Conclusion Dill powder supplementation can be effective in controlling the glycemic, lipid, stress oxidative and gastrointestinal symptoms in patients with type 2 diabetes. Trial registration Iran Clinical Trials Registry: IRCT20120704010181N12 . Registered on 12 May 2018. |
topic |
Type 2 diabetes Dill powder Glycemic control Lipid profile Stress oxidative status |
url |
http://link.springer.com/article/10.1186/s13063-020-04401-3 |
work_keys_str_mv |
AT fatemehhaidari theeffectsofanethumgraveolensdillpowdersupplementationonclinicalandmetabolicstatusinpatientswithtype2diabetes AT mehrnooshzakerkish theeffectsofanethumgraveolensdillpowdersupplementationonclinicalandmetabolicstatusinpatientswithtype2diabetes AT fatemehborazjani theeffectsofanethumgraveolensdillpowdersupplementationonclinicalandmetabolicstatusinpatientswithtype2diabetes AT kambizahmadiangali theeffectsofanethumgraveolensdillpowdersupplementationonclinicalandmetabolicstatusinpatientswithtype2diabetes AT golnazamoochiforoushani theeffectsofanethumgraveolensdillpowdersupplementationonclinicalandmetabolicstatusinpatientswithtype2diabetes AT fatemehhaidari effectsofanethumgraveolensdillpowdersupplementationonclinicalandmetabolicstatusinpatientswithtype2diabetes AT mehrnooshzakerkish effectsofanethumgraveolensdillpowdersupplementationonclinicalandmetabolicstatusinpatientswithtype2diabetes AT fatemehborazjani effectsofanethumgraveolensdillpowdersupplementationonclinicalandmetabolicstatusinpatientswithtype2diabetes AT kambizahmadiangali effectsofanethumgraveolensdillpowdersupplementationonclinicalandmetabolicstatusinpatientswithtype2diabetes AT golnazamoochiforoushani effectsofanethumgraveolensdillpowdersupplementationonclinicalandmetabolicstatusinpatientswithtype2diabetes |
_version_ |
1724755362896150528 |